Telavancin Intravenous and Nephrotoxicity
Result of checking the interaction of drug Telavancin Intravenous and disease Nephrotoxicity for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Telavancin may increase the risk of nephrotoxicity in patients predisposed to kidney dysfunction (preexisting renal disease, diabetes mellitus, congestive heart failure, or hypertension) and in those taking medications known to affect kidney function. It is recommended to monitor renal function (i.e., serum creatinine, creatinine clearance) prior to initiation of therapy, during treatment, and at the end of treatment in all patients receiving telavancin; and if renal function decreases, the benefit of continuing therapy versus discontinuing and initiating therapy with an alternative agent should be assessed.
Generic Name: telavancin
Brand Name: Vibativ
Synonyms: Telavancin
Telavancin Intravenous - nefrotoksyczność 
Telavancin Intravenous - nefrotoxicidade 
Telavancin Intravenous - nefrotoksisiti 
Telavancin Intravenous - nefrotoksisitas 
Telavancin Intravenous - nefrotossicità 
Telavancin Intravenous - néphrotoxicité 
Telavancin Intravenous - Nephrotoxizität 
Telavancin Intravenous - nefrotoxicidad 
Telavancin Intravenous - нефротоксичность 
Telavancin Intravenous - nefrotoksisite 
Telavancin Intravenous - السمية الكلوية 
Telavancin Intravenous - 肾毒性